Epigenetic regulation of drug processing genes

References

• Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S. 2001. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120:1689–1699.
   PubMed Web of Science ®Google Scholar
• Aoki M, Terada T, Kajiwara M, Ogasawara K, Ikai I, Ogawa O, Katsura T, Inui K. 2008. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Renal Physiol 295:F165–F170.
   PubMed Web of Science ®Google Scholar
• Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. 2008. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol Rep 19:211–216.
   Google Scholar
• Baker EK, El-Osta A. 2010. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing. Methods Mol Biol 596:183–198.
   PubMedGoogle Scholar
• Baker EK, Johnstone RW, Zalcberg JR, El-Osta A. 2005. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Oncogene 24:8061–8075.
   PubMed Web of Science ®Google Scholar
• Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. 2010. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 329:1537–1541.
   PubMed Web of Science ®Google Scholar
• Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. 2010. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Mol Pharmacol 78:608–616.
   PubMed Web of Science ®Google Scholar
• Bélanger AS, Tojcic J, Harvey M, Guillemette C. 2010. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. BMC Mol Biol 11:9.
   PubMed Web of Science ®Google Scholar
• Bellemare J, Rouleau M, Harvey M, Têtu B, Guillemette C. 2010. Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines. Pharmacogenomics J 10:431–441.
   PubMed Web of Science ®Google Scholar
• Bram EE, Stark M, Raz S, Assaraf YG. 2009. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance. Neoplasia 11:1359–1370.
   PubMed Web of Science ®Google Scholar
• Calcagno AM, Fostel JM, To KK, Salcido CD, Martin SE, Chewning KJ, Wu CP, Varticovski L, Bates SE, Caplen NJ, Ambudkar SV. 2008. Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer 98:1515–1524.
   PubMed Web of Science ®Google Scholar
• Chan QK, Khoo US, Chan KY, Ngan HY, Li SS, Chiu PM, Man LS, Ip PP, Xue WC, Cheung AN. 2005. Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma. J Mol Diagn 7:8–16.
   PubMed Web of Science ®Google Scholar
• Chatterjee B, Echchgadda I, Song CS. 2005. Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1. Meth Enzymol 400:165–191.
   PubMed Web of Science ®Google Scholar
• Cheung C, Akiyama TE, Kudo G, Gonzalez FJ. 2003. Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice. Biochem Pharmacol 66:2011–2020.
   PubMed Web of Science ®Google Scholar
• Choudhuri S, Cui Y, Klaassen CD. 2010. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 245:378–393.
   PubMed Web of Science ®Google Scholar
• Cui JY, Choudhuri S, Knight TR, Klaassen CD. 2010. Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol Sci 116:32–43.
   PubMed Web of Science ®Google Scholar
• Cui YJ, Yeager RL, Zhong XB, Klaassen CD. 2009. Ontogenic expression of hepatic Ahr mRNA is associated with histone H3K4 di-methylation during mouse liver development. Toxicol Lett 189:184–190.
   Google Scholar
• Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Obertone TS, Sitaraman SV, Merlin D. 2011. MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 300:G52–G59.
   PubMed Web of Science ®Google Scholar
• David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson WG. 2004. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. Cancer Biol Ther 3:540–548.
   PubMed Web of Science ®Google Scholar
• El-Khoury V, Breuzard G, Fourré N, Dufer J. 2007. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. Br J Cancer 97:562–573.
   PubMed Web of Science ®Google Scholar
• Gagnon JF, Bernard O, Villeneuve L, Têtu B, Guillemette C. 2006. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. Clin Cancer Res 12:1850–1858.
   PubMed Web of Science ®Google Scholar
• Gao P, Yang X, Xue YW, Zhang XF, Wang Y, Liu WJ, Wu XJ. 2009. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression. Cancer 115:3222–3232.
   Google Scholar
• Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC. 2001. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357–368.
   PubMedGoogle Scholar
• Gonzalez FJ. 2007. The 2006 Bernard B. Brodie Award Lecture. CYP2E1. Drug Metab Dispos 35:1–8.
   PubMed Web of Science ®Google Scholar
• Habano W, Gamo T, Sugai T, Otsuka K, Wakabayashi G, Ozawa S. 2009. CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. Int J Oncol 34:1085–1091.
   PubMed Web of Science ®Google Scholar
• Hatzis P, Talianidis I. 2002. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol Cell 10:1467–1477.
   PubMed Web of Science ®Google Scholar
• Hauswald S, Duque-Afonso J, Wagner MM, Schertl FM, Lübbert M, Peschel C, Keller U, Licht T. 2009. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Clin Cancer Res 15:3705–3715.
   PubMed Web of Science ®Google Scholar
• Hoffman BG, Robertson G, Zavaglia B, Beach M, Cullum R, Lee S, Soukhatcheva G, Li L, Wederell ED, Thiessen N, Bilenky M, Cezard T, Tam A, Kamoh B, Birol I, Dai D, Zhao Y, Hirst M, Verchere CB, Helgason CD, Marra MA, Jones SJ, Hoodless PA. 2010. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res 20:1037–1051.
   PubMed Web of Science ®Google Scholar
• Huang C, Cao P, Xie Z. 2009. Relation of promoter methylation of MDR-1 gene and histone acetylation status with multidrug resistance in MCF-7/Adr cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34:369–374.
   Google Scholar
• Huo H, Magro PG, Pietsch EC, Patel BB, Scotto KW. 2010. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance. Cancer Res 70:8726–8735.
   PubMed Web of Science ®Google Scholar
• Ichihara S, Kikuchi R, Kusuhara H, Imai S, Maeda K, Sugiyama Y. 2010. DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines. Pharm Res 27:510–516.
   PubMed Web of Science ®Google Scholar
• Imai S, Kikuchi R, Kusuhara H, Yagi S, Shiota K, Sugiyama Y. 2009. Analysis of DNA methylation and histone modification profiles of liver-specific transporters. Mol Pharmacol 75:568–576.
   PubMed Web of Science ®Google Scholar
• Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N. 1998. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res 58:5310–5314.
   PubMed Web of Science ®Google Scholar
• Jiang ZP, Xu P, Liu RR, Li HD, Wang GP, Zhao XL, Chen FP. 2008. Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects. Pharmacogenomics 9:1801–1808.
   Google Scholar
• Jiang ZP, Xu P, Wang GP, Zhao XL, Chen FP. 2010. Hypothesizing that histone deacetylase inhibitors can be used to reverse multiple drug resistance. Med Hypotheses 74:92–94.
   PubMed Web of Science ®Google Scholar
• Jin B, Park DW, Nam KW, Oh GT, Lee YS, Ryu DY. 2004. CpG methylation of the mouse CYP1A2 promoter. Toxicol Lett 152:11–18.
   Google Scholar
• Jirtle RL, Skinner MK. 2007. Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262.
   PubMed Web of Science ®Google Scholar
• Kang Z, Jänne OA, Palvimo JJ. 2004. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 18:2633–2648.
   PubMedGoogle Scholar
• Kemper JK, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D, Tsang S, Wu SY, Chiang CM, Veenstra TD. 2009. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab 10:392–404.
   PubMed Web of Science ®Google Scholar
• Kikuchi R, Kusuhara H, Hattori N, Kim I, Shiota K, Gonzalez FJ, Sugiyama Y. 2007. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. Mol Pharmacol 72:1619–1625.
   PubMed Web of Science ®Google Scholar
• Kikuchi R, Kusuhara H, Hattori N, Shiota K, Kim I, Gonzalez FJ, Sugiyama Y. 2006. Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. Mol Pharmacol 70:887–896.
   PubMed Web of Science ®Google Scholar
• Kikuchi R, Yagi S, Kusuhara H, Imai S, Sugiyama Y, Shiota K. 2010. Genome-wide analysis of epigenetic signatures for kidney-specific transporters. Kidney Int 78:569–577.
   PubMed Web of Science ®Google Scholar
• Kim SN, Kim NH, Lee W, Seo DW, Kim YK. 2009. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region. Mol Cancer Res 7:735–744.
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A, Jarrard DF. 2000. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res 60:3623–3630.
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Aleksunes LM. 2010. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1–96.
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Reisman SA. 2010. Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol Appl Pharmacol 244:57–65.
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Lu H. 2008. Xenobiotic transporters: ascribing function from gene knockout and mutation studies. Toxicol Sci 101:186–196.
   PubMed Web of Science ®Google Scholar
• Knight TR, Choudhuri S, Klaassen CD. 2007. Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol Sci 100:513–524.
   PubMed Web of Science ®Google Scholar
• Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP. 2008. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7:2152–2159.
   PubMed Web of Science ®Google Scholar
• Kurian JR, Olesen KM, Auger AP. 2010. Sex differences in epigenetic regulation of the estrogen receptor-alpha promoter within the developing preoptic area. Endocrinology 151:2297–2305.
   PubMed Web of Science ®Google Scholar
• Kwon MS, Kim SJ, Lee SY, Jeong JH, Lee ES, Kang HS. 2006. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue. Oncol Rep 15:27–32.
   PubMed Web of Science ®Google Scholar
• Lee J, Padhye A, Sharma A, Song G, Miao J, Mo YY, Wang L, Kemper JK. 2010. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 285:12604–12611.
   PubMed Web of Science ®Google Scholar
• Lévesque E, Girard H, Journault K, Lépine J, Guillemette C. 2007. Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128–138.
   PubMed Web of Science ®Google Scholar
• Li WQ, Li YM, Tao BB, Lu YC, Hu GH, Liu HM, He J, Xu Y, Yu HY. 2010a. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Med Sci Monit 16:HY27–HY30.
   PubMed Web of Science ®Google Scholar
• Li Y, Cui Y, Hart SN, Klaassen CD, Zhong XB. 2009. Dynamic patterns of histone methylation are associated with ontogenic expression of the CYP3A genes during mouse liver maturation. Mol Pharmacol 75:1171–1179.
   PubMed Web of Science ®Google Scholar
• Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z. 2010b. miR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol 119:125–130.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H. 2010. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817–824.
   PubMed Web of Science ®Google Scholar
• Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA, Burdge GC. 2007. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 97:1064–1073.
   PubMed Web of Science ®Google Scholar
• Ling G, Hauer CR, Gronostajski RM, Pentecost BT, Ding X. 2004. Transcriptional regulation of rat CYP2A3 by nuclear factor 1: identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo. J Biol Chem 279:27888–27895.
   PubMed Web of Science ®Google Scholar
• Ling G, Wei Y, Ding X. 2007. Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation. Mol Pharmacol 71:807–816.
   Google Scholar
• Lockhart AC, Tirona RG, Kim RB. 2003. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol Cancer Ther 2:685–698.
   PubMed Web of Science ®Google Scholar
• Lu H, Gonzalez FJ, Klaassen C. 2010. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. Toxicol Sci 118:380–390.
   PubMed Web of Science ®Google Scholar
• Luco RF, Maestro MA, Sadoni N, Zink D, Ferrer J. 2008. Targeted deficiency of the transcriptional activator HNF1alpha alters subnuclear positioning of its genomic targets. PLoS Genet 4:e1000079.
   PubMedGoogle Scholar
• Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheung C, Gonzalez FJ, Klaassen CD. 2006. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol 72:512–522.
   PubMed Web of Science ®Google Scholar
• Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313–1316.
   PubMed Web of Science ®Google Scholar
• Martiniova L, Perera SM, Brouwers FM, Alesci S, Abu-Asab M, Marvelle AF, Kiesewetter DO, Thomasson D, Morris JC, Kvetnansky R, Tischler AS, Reynolds JC, Fojo AT, Pacak K. 2011. Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors. Endocr Relat Cancer 18:143–157.
   PubMed Web of Science ®Google Scholar
• McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ. 2009. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348.
   PubMed Web of Science ®Google Scholar
• Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, Yokoi T. 2010. Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79:1045–1052.
   PubMed Web of Science ®Google Scholar
• Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T. 2009. MicroRNA regulates human vitamin D receptor. Int J Cancer 125:1328–1333.
   PubMed Web of Science ®Google Scholar
• Monks NR, Liu S, Xu Y, Yu H, Bendelow AS, Moscow JA. 2007. Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells. Mol Cancer Ther 6:587–598.
   PubMed Web of Science ®Google Scholar
• Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J. 2010. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res 12:R3.
   Google Scholar
• Mulero-Navarro S, Carvajal-Gonzalez JM, Herranz M, Ballestar E, Fraga MF, Ropero S, Esteller M, Fernandez-Salguero PM. 2006. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis 27:1099–1104.
   PubMed Web of Science ®Google Scholar
• Murphy BC, O’Reilly RL, Singh SM. 2005. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am J Med Genet B Neuropsychiatr Genet 133B:37–42.
   Google Scholar
• Muto M, Onogawa T, Suzuki T, Ishida T, Rikiyama T, Katayose Y, Ohuchi N, Sasano H, Abe T, Unno M. 2007. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci 98:1570–1576.
   PubMed Web of Science ®Google Scholar
• Pan YZ, Gao W, Yu AM. 2009. MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112–2117.
   PubMed Web of Science ®Google Scholar
• Phillips JM, Goodman JI. 2009. Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors. Toxicol Sci 108:273–289.
   PubMed Web of Science ®Google Scholar
• Phillips JM, Yamamoto Y, Negishi M, Maronpot RR, Goodman JI. 2007. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis. Toxicol Sci 96:72–82.
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O. 2010. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 127:1785–1794.
   PubMed Web of Science ®Google Scholar
• Pontoglio M, Faust DM, Doyen A, Yaniv M, Weiss MC. 1997. Hepatocyte nuclear factor 1alpha gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene. Mol Cell Biol 17:4948–4956.
   PubMedGoogle Scholar
• Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS. 1992. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267:3257–3261.
   PubMed Web of Science ®Google Scholar
• Sangokoya C, Telen MJ, Chi JT. 2010. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 116:4338–4348.
   PubMed Web of Science ®Google Scholar
• Schnekenburger M, Peng L, Puga A. 2007a. HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim Biophys Acta 1769:569–578.
   PubMedGoogle Scholar
• Schnekenburger M, Talaska G, Puga A. 2007b. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol Cell Biol 27:7089–7101.
   PubMed Web of Science ®Google Scholar
• Sharma D, Saxena NK, Davidson NE, Vertino PM. 2006. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res 66:6370–6378.
   PubMed Web of Science ®Google Scholar
• Sharma G, Mirza S, Parshad R, Srivastava A, Datta Gupta S, Pandya P, Ralhan R. 2010. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem 43:373–379.
   PubMed Web of Science ®Google Scholar
• Sikand K, Slaibi JE, Singh R, Slane SD, Shukla GC. 2010. miR 488* inhibits androgen receptor expression in prostate carcinoma cells. Int J Cancer. (In Press).
   Google Scholar
• Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ. 2003. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573–582.
   PubMed Web of Science ®Google Scholar
• Suter M, Abramovici A, Showalter L, Hu M, Shope CD, Varner M, Aagaard-Tillery K. 2010. In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metab Clin Exp 59:1481–1490.
   PubMed Web of Science ®Google Scholar
• Tabe Y, Konopleva M, Contractor R, Munsell M, Schober WD, Jin L, Tsutsumi-Ishii Y, Nagaoka I, Igari J, Andreeff M. 2006. Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells. Blood 107:1546–1554.
   PubMedGoogle Scholar
• Tahara T, Arisawa T, Shibata T, Yamashita H, Yoshioka D, Hirata I. 2009a. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. Anticancer Res 29:337–341.
   Google Scholar
• Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakagawa Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I, Arisawa T. 2009b. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med 23:521–527.
   PubMed Web of Science ®Google Scholar
• Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, Yokoi T. 2010. MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285:4415–4422.
   PubMed Web of Science ®Google Scholar
• Takagi S, Nakajima M, Mohri T, Yokoi T. 2008. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283:9674–9680.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Suzuki C, Kamataki T. 1998. Silencing of CYP1A1 expression in rabbits by DNA methylation. Biochem Biophys Res Commun 247:383–386.
   PubMed Web of Science ®Google Scholar
• To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE. 2009. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther 8:2959–2968.
   PubMed Web of Science ®Google Scholar
• To KK, Zhan Z, Bates SE. 2006. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol 26:8572–8585.
   PubMed Web of Science ®Google Scholar
• To KK, Zhan Z, Litman T, Bates SE. 2008. Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 28:5147–5161.
   PubMed Web of Science ®Google Scholar
• Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R. 2005. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 11:5793–5801.
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T. 2006. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090–9098.
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. 2007. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 47:566–578.
   PubMed Web of Science ®Google Scholar
• Viollet B, Yaniv M, Pontoglio M. 2001. Embryonic but not postnatal reexpression of hepatocyte nuclear factor 1alpha (HNF1alpha) can reactivate the silent phenylalanine hydroxylase gene in HNF1alpha-deficient hepatocytes. Mol Cell Biol 21:3662–3670.
   PubMedGoogle Scholar
• Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, Cheng ML, Diwan BA. 2004. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst 96:466–474.
   PubMed Web of Science ®Google Scholar
• Wakefield L, Boukouvala S, Sim E. 2010. Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism. Gene 452:16–21.
   Google Scholar
• Wang F, Xue X, Wei J, An Y, Yao J, Cai H, Wu J, Dai C, Qian Z, Xu Z, Miao Y. 2010. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 103:567–574.
   PubMed Web of Science ®Google Scholar
• Weaver IC. 2007. Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let’s call the whole thing off. Epigenetics 2:22–28.
   PubMed Web of Science ®Google Scholar
• Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. 2004. Epigenetic programming by maternal behavior. Nat Neurosci 7:847–854.
   PubMed Web of Science ®Google Scholar
• Wei YD, Tepperman K, Huang MY, Sartor MA, Puga A. 2004. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J Biol Chem 279:4110–4119.
   PubMed Web of Science ®Google Scholar
• Westberry JM, Trout AL, Wilson ME. 2010. Epigenetic regulation of estrogen receptor alpha gene expression in the mouse cortex during early postnatal development. Endocrinology 151:731–740.
   Google Scholar
• Wiwi CA, Gupte M, Waxman DJ. 2004. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol Endocrinol 18:1975–1987.
   PubMed Web of Science ®Google Scholar
• Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249–268.
   PubMed Web of Science ®Google Scholar
• Yagi S, Hirabayashi K, Sato S, Li W, Takahashi Y, Hirakawa T, Wu G, Hattori N, Hattori N, Ohgane J, Tanaka S, Liu XS, Shiota K. 2008. DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res 18:1969–1978.
   Google Scholar
• Yatouji S, El-Khoury V, Trentesaux C, Trussardi-Regnier A, Benabid R, Bontems F, Dufer J. 2007. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines. Int J Oncol 30:1003–1009.
   PubMed Web of Science ®Google Scholar
• Yokomori N, Kobayashi R, Moore R, Sueyoshi T, Negishi M. 1995. A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP. Mol Cell Biol 15:5355–5362.
   PubMed Web of Science ®Google Scholar
• Yu S, Khor TO, Cheung KL, Li W, Wu TY, Huang Y, Foster BA, Kan YW, Kong AN. 2010. Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PLoS ONE 5:e8579.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X. 2010. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 55:2545–2551.
   PubMed Web of Science ®Google Scholar
• Zhao A, Cheng Y, Li X, Li Q, Wang L, Xu J, Xiang Y, Xing Q, He L, Zhao X. 2011. Promoter hypomethylation of COMT in human placenta is not associated with the development of pre-eclampsia. Mol Hum Reprod 17:199–206.
   PubMed Web of Science ®Google Scholar
• Zheng L, Lv GC, Sheng J, Yang YD. 2010. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 25:156–163.
   PubMed Web of Science ®Google Scholar